JAK2 and acute myeloid leukemia: It has been demonstrated that several additional genetic alterations, which are engaged in epigenetic regulation, cell-growth signaling, and RNA splicing machinery, cooperate with JAK2, CALR, or MPL mutation for the transformation to AML from ET7–9.